Mumbai, India

Gandhali Ashwin Deshpande

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gandhali Ashwin Deshpande

Introduction

Gandhali Ashwin Deshpande, a prominent inventor based in Mumbai, India, has made significant strides in the field of pharmaceuticals. With a total of four patents to his name, Deshpande is noted for his innovative approaches to the treatment of cancers associated with human papillomavirus.

Latest Patents

His latest patents focus on the development of compounds for the treatment of cancers associated with human papillomavirus. The present invention relates to pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer, or a diastereoisomer thereof. These inventions include pharmaceutical compositions containing the compounds of Formula (I), aiming to provide effective treatments for patients suffering from these cancers.

Career Highlights

Gandhali Ashwin Deshpande is currently associated with Piramal Enterprises Limited, a leading name in the pharmaceutical industry. His work focuses on innovating and creating groundbreaking solutions that address critical health issues.

Collaborations

In his pursuit of innovation, Deshpande collaborates with notable colleagues, including Swati Ajay Piramal and Muralidhara Padigaru. Their collective expertise and commitment to research foster an environment conducive to pioneering advancements in medical treatments.

Conclusion

Gandhali Ashwin Deshpande's contributions to the field of pharmaceutical innovation underscore the importance of dedicated research and collaboration. As he continues to develop new treatments for cancers associated with human papillomavirus, his work promises to make a lasting impact on the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…